QR koda

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis

Abstract Background A significant proportion of patients with severe asthma may also suffer from nasal polyposis, which is commonly defined as chronic rhinosinusitis with nasal polyps (CRSwNP), the presence of which may adversely affect asthma treatment outcomes. The biologic agent omalizumab is eff...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Principais autores: Enrico Heffler, Fabiana Saccheri, Marta Bartezaghi, Giorgio Walter Canonica
Format: Artigo
Jezik:Inglês
Izdano: Wiley 2020-06-01
Serija:Clinical and Translational Allergy
Teme:
Online dostop:http://link.springer.com/article/10.1186/s13601-020-00330-1
Oznake: Označite
Brez oznak, prvi označite!